Cardiogenic shock (CS) is the most severe form of acute heart failure. Discrepancies have been reported between sexes regarding delays, pathways and invasive strategies in CS complicating acute myocardial infarction. However, effect of sex on the prognosis of unselected CS remains controversial.
ObjectivesThe aim was to analyze the impact of sex on aetiology, management and prognosis of CS.
MethodsThe FRENSHOCK registry included all CS admitted in 49 French Intensive Care Units (ICU) and Intensive Cardiac Care Units (ICCU) between April and October 2016.
ResultsAmong the 772 CS patients included, 220 were women (28.5%). Women were older, less smokers, with less history of ischemic cardiac disease (20.5% vs 33.6%) than men. At admission, women presented less cardiac arrest (5.5 vs 12.2%), less mottling (32.5 vs 41.4%) and higher LVEF (30 ± 14 vs 25 ± 13%). Women were more often managed via emergency department while men were directly admitted at ICU/ICCU. Ischemia was the most frequent trigger irrespective of sex (36.4% in women vs 38.2%) but women had less coronary angiogram and PCI (45.9% vs 54% and 24.1 vs 31.3%, respectively). We found no major difference in medication and organ support. Thirty-day mortality (26.4 vs 26.5%), transplant or permanent assist device were similar in both sexes.
ConclusionDespite some more favorable parameters in initial presentation and no significant difference in medication and support, women shared similar poor prognosis than men. Further analysis is required to cover the lasting gap in knowledge regarding sex specificities to distinguish between differences and inequalities. NCT02703038
KeywordsCardiogenic shock
Sex
Epidemiology
Management
Prognosis
AbbreviationsACSacute coronary syndrome;
AMIacute myocardial infarction;
AMICSacute myocardial infarction associated cardiogenic shock;
CAGcoronary artery angiogram;
ECLSextracorporeal life support;
ICCUintensive cardiac care unit;
LVEFleft ventricular ejection fraction;
MCSmechanical circulatory support;
PCIPercutaneous Coronary Intervention,
VADventricular assist device.
© 2024 The Authors. Published by Elsevier Inc.
Comments (0)